Publications by authors named "Ziqiang She"
[Clinical study on Rituximab in the treatment of idiopathic thrombotic thrombocytopenic purpura].
Zhonghua Xue Ye Xue Za Zhi
April 2015
Objective: To study the efficacy and safety of rituximab (RTX) in the treatment of idiopathic thrombotic thrombocytopenic purpura (ITTP).
Methods: Among 17 ITTP patients, nine cases of the RTX group were administrated with RTX plus plasma exchange (PEX) and steroids. Eight cases of the control group received PEX plus steroids±other immune inhibitors.